By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Includes articles, courses, and CPGs. Unlimited access for APTA members.
May 23, 2017/Test & Measure
Patients self rate the presence and severity of signs and symptoms such as blurred vision, dizziness, drowsiness, sleeping more than usual, easily distracted, fatigue, feeling “in a fog,” headache, and irritability.
Aug 23, 2017/Test & Measure
A 6 point Oxford scale (0=no contraction, 1=flicker, 2=weak, 3=moderate, 4=good (with lift), and 5=strong) used during internal examination to measure pelvic floor muscle strength in women. (4)
Nov 1, 2025/Column
APTA President Kyle Covington, PT, DPT, PhD, recalls a memorable patient encounter in this issue’s column.
Apr 27, 2022/Podcast
A volunteer guideline development group of APTA has developed a clinical practice guideline on Parkinson disease.
Apr 22, 2022/News
SWORD Health has committed at least $100k annually to bolster the study of technology use in the profession, and to grow APTA’s PT Fund.
Jan 21, 2022/News
The changes, many of which could affect PTs, will begin April 13. Now's the time to prepare.
Mar 5, 2021/Roundup
APTA joins national vaccine campaign, Biden updates distribution timeline, insurers launch pilot program, and more.
Jul 27, 2021/Podcast
n a descriptive study that’s already been featured in 14 news stories, Mark Werneke, PT, and colleagues analyzed data on more than 222,000 patients in the Focus on Therapeutic Outcomes database. Werneke and Jette talk in depth about the relatively low use of telerehabilitation in the outpatient population
May 8, 2020/Article
Our first century saw war, public health crises, and the continued growth of our association in strength and numbers.
Feb 27, 2023/Perspective
For me, remembering the "why" of becoming a PT is the privilege we have of entering another's experience.
